CERT (Health Care Technology) Stock Valuation & Fair Value Trading above fair value
CERT (Health Care Technology) trades at a blended P/E of 19.1, about 71% below its historical normal valuation, with a forward growth estimate of 5.2% and a PEG of 3.64. Analysts' one-year estimates have been hit 50% of the time.
Valuation flags
- High PEG (3.6x)
Frequently asked questions
Is CERT overvalued?
At a blended P/E of 19.1 versus its historical normal P/E of 66.7, CERT trades about 71% below its typical valuation, with a PEG of 3.64 on 5.2% forward growth. tickerseer currently rates it trading above fair value.
What is CERT's fair value and PEG?
CERT trades at a blended P/E of 19.1 against a historical normal P/E of 66.7, a PEG of 3.64, and a forward growth estimate of 5.2%.
Has tickerseer's rating of CERT changed?
tickerseer's rating has been trading above fair value since 2026-07-31.
Industry: Health Care Technology. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.